This Semtech Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Analysts upgraded Zeta, Fox, Greif, Semtech and EchoStar, raising ratings and setting higher price targets.
Stocks · News reference
U.S. futures rise, but Xenon plunges 27.6% after pausing psychiatry trial enrollment over neuropsychiatric adverse events; other stocks also fall
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts upgraded Zeta, Fox, Greif, Semtech and EchoStar, raising ratings and setting higher price targets.
Analysts raised targets for TSM, MRNA, ALEC and WMT; cut AZZ, ARRY and ALGN targets, upgrading ARRY/WMT and downgrading ALGN.
Analysts upgraded BAC, WMT, QNT, ARRY and ZION; price targets rose for WMT but fell for QNT and ARRY.
Mizuho analyst Maheep Mandloi upgrades Array Technologies (NASDAQ:ARRY) from Neutral to Outperform and lowers the price target from $7 to $5.
Filed: 2026-10-15 AccNo: 0001935979-26-000080 Size: 961 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Biohaven signs a $100 million Asian licensing agreement with Ono Pharmaceutical for its Phase 3 MoDE pan IgG degrader portfolio.